Literature DB >> 1385965

Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations.

J Maj1, E Moryl.   

Abstract

The effect of repeated treatment (5 and 10 mg/kg, po, twice daily, 14 days) with sertraline and citalopram (antidepressants which selectively inhibit the reuptake of 5-hydroxytryptamine (5-HT)) on the responsiveness of different 5-HT receptors to their agonists, was examined in rats and mice. Sertraline and citalopram (both at a dose 5 and 10 mg/kg) antagonized (the first one more potently) the hypothermia induced in mice by 8-OH-DPAT (a 5-HT1A agonist), but not the behavioural syndrome induced in rats by this substance. The m-chlorophenylpiperazine-induced hypothermia in mice (a 5-HT1B effect) was increased by sertraline and citalopram (only in a dose of 10 mg/kg). Both antidepressants, given repeatedly (as well acutely) attenuated exploratory hypoactivity induced in rats by m-chlorophenylpiperazine (a 5-HT1C effect). L-5-HTP-induced head twitches in mice (5-HT2 effect) were antagonized dose-dependently by both repeated sertraline and citalopram. Both antidepressants (citalopram only in higher dose) reduced the fenfluramine-induced hyperthermia in rats (5-HT2 effect). The results indicate that sertraline and citalopram given repeatedly decrease the responsiveness of 5-HT1A (presynaptic) and 5-HT2 receptors but increase the responsiveness of 5-HT1B receptors to respective agonists.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385965     DOI: 10.1007/bf01244819

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  29 in total

1.  Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.

Authors:  B K Koe; S W Koch; L A Lebel; K W Minor; M G Page
Journal:  Eur J Pharmacol       Date:  1987-09-11       Impact factor: 4.432

2.  Antagonism of fenfluramine-induced hyperthermia: a measure of central serotonin inhibition.

Authors:  A Sulpizio; P J Fowler; E Macko
Journal:  Life Sci       Date:  1978-04-24       Impact factor: 5.037

3.  Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain.

Authors:  Y Chaput; C de Montigny; P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

4.  A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.

Authors:  G M Goodwin; A R Green
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

5.  A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments.

Authors:  J G Hensler; G B Kovachich; A Frazer
Journal:  Neuropsychopharmacology       Date:  1991-02       Impact factor: 7.853

6.  Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.

Authors:  J Hyttel; K F Overø; J Arnt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

8.  Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.

Authors:  J Arnt; K F Overø; J Hyttel; R Olsen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.

Authors:  J Yamada; Y Sugimoto; K Horisaka
Journal:  Eur J Pharmacol       Date:  1988-09-23       Impact factor: 4.432

10.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

Authors:  S J CORNE; R W PICKERING; B T WARNER
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  13 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.

Authors:  Thibault Renoir; Terence Y C Pang; Michelle S Zajac; Grace Chan; Xin Du; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.

Authors:  J Benjamin; B D Greenberg; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

4.  The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.

Authors:  J Maj; M Bijak; M Dziedzicka-Wasylewska; R Rogoz; Z Rogóz; G Skuza; T Tokarski
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

5.  Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

Authors:  G Griebel; J L Moreau; F Jenck; R Misslin; J R Martin
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

6.  EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.

Authors:  R H McAllister-Williams; A E Massey
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

7.  Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.

Authors:  K B Troelsen; E Ø Nielsen; N R Mirza
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

8.  Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area.

Authors:  S Prisco; E Esposito
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.

Authors:  A J Kennedy; E L Gibson; M T O'Connell; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.

Authors:  V Klimek; J Zak-Knapik; M Mackowiak
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.